This article presents global cancer statistics by world region for the year 2022 based on
updated estimates from the International Agency for Research on Cancer (IARC). There …

Drug resistance in hepatocellular carcinoma has posed significant obstacles to effective
treatment. Recent evidence indicates that, in addition to traditional gene mutations …

Chronic hepatitis B (CHB) was, and still is, a prevalent liver disease in the world, especially
high in the Asia‐Pacific areas. With the advent of preventive vaccines and effective viral …

Due to the comprehensive hepatitis B virus vaccination program in Taiwan since 1986, the
development of antiviral therapy for chronic hepatitis B and chronic hepatitis C infection and …

More than 290 million people worldwide, and almost 2 million people in the United States,
are infected with hepatitis B virus, which can lead to chronic hepatitis B, a vaccine …

An incomplete Freund's adjuvant elicited an overt pathogenesis in vaccinated mice following
the intranasal challenge of A/California/07/2009 (H1N1) virus despite the induction of a …

Background and aims Hepatitis B virus (HBV) vaccination programs in Taiwan are one of the
earliest programs in the world and have largely reduced the prevalence of HBV infection …

Annually, more than 1.5 million preventable new hepatitis B (HBV) infections continue to
occur, with an estimated global burden of 296 million individuals living with chronic hepatitis …

It took many centuries, perhaps a dozen or more, for the 3-millenium-old practice of
Hepatoscopy [also known as Haruspicy and Hepatomancy], ie, an inspection of the liver for …

Sodium taurocholate co-transporting polypeptide (NTCP), a bile acid transporter, plays a
crucial role in regulating bile acid levels and influencing the risk of HBV infection. Genetic …